ABSTRACT
INTRODUCTION
In 2009, there were 1832 new liver cancer cases in Hong Kong, representing 14% of all new cancers in Hong Kong. 1 Surgical resection of tumours is considered to be the only curative treatment. Unfortunately, hepatocellular carcinoma may present late and may be non-resectable by the time the patient seeks medical attention. For such patients, there are other methods for disease control such as conformal radiotherapy, radiofrequency ablation, and transarterial chemoembolisation. The use of radioembolisation with Yttrium-90 ( 90 Y)-labelled microspheres has been applied as an alternative treatment method to inoperable primary liver tumours and liver metastases. 90 Y is a pure beta-particle emitter with a physical half-life of 64 hours and average path length in soft tissue of 4 mm, making it well suited for reasonably uniform irradiation of bulky tumours, while minimising the radiation dose to surrounding normal tissues. [3] [4] [5] In-vivo imaging of pure beta-particle emitters is generally problematic because of the very limited penetrability of beta particles through tissue. However, Bremsstrahlung, or "brake X-rays", are produced in small but imageable amounts by the higherenergy beta particles as they pass through matter and interact inelastically with atomic nuclei. The resulting X-ray energy spectrum is continuous, with a large proportion of the resulting X-rays having energies closer to zero, and progressively fewer X-rays having energies approaching the maximum, or end-point, energy of the beta particles. This broad distribution, skewed towards lower-energy X-rays, coupled with the small number of X-rays actually emitted (due to the small number of radioactive vs collisional energy-loss interactions) results in coarse energy and spatial resolution and, thus, limited detectability of small lesions by gamma Y PET/CT may not be visualised by Bremsstrahlung SPECT/CT system (Hawkeye 4; GE Medical, USA). 9 In cases where there is nontarget extrahepatic uptake in close proximity to the liver, the coregistered PET/CT images will enhance the diagnostic confidence in image interpretation. 
CONCLUSION

